Navigation Links
Adjunct Breast Imaging Market to Increase by Almost 28% per Year Through 2013
Date:8/7/2008

Radiologists expect dedicated breast MRIs to skyrocket over the next five

years, according to Millennium Research Group

WALTHAM, Mass., Aug. 7 /PRNewswire/ -- According to Millennium Research Group's (MRG) US Markets for Women's Health Imaging Systems 2008 report, the market for adjunct breast imaging systems -- covering breast magnetic resonance imaging (MRI) coils, dedicated breast MRI systems, and breast-specific gamma imaging (BSGI) systems -- will grow at a compound annual growth rate (CAGR) of almost 28% over the next five years.

Given the dramatic growth exhibited by these market segments, MRG conducted a survey of radiologists who regularly perform breast imaging procedures in order to gauge the future adoption of breast imaging modalities. The respondents showed a strong preference for breast MRI, particularly dedicated breast MRI, the fastest-growing market segment. On average, only 4% of breast imaging procedures employed MRI in 2008, yet almost all respondents expect this modality to be more heavily used by 2013, fueled by both falling procedure costs and improved image quality.

"Although we expected MRI to post a strong showing due to its proven clinical capabilities, it was surprising to see just how important radiologists expect dedicated breast MRI systems to become by 2013," says David Plow, Manager of MRG's Imaging division. "This trend is particularly enlightening when you consider the rankings other breast imaging modalities received when the respondents were asked to forecast system popularity five years out."

The US Markets for Women's Health Imaging Systems 2008 report provides coverage of all key industry competitors, including FUJIFILM Medical Systems, GE Healthcare, Hologic, Invivo Diagnostic Imaging, Philips Healthcare, Siemens Healthcare, and many more.

About Millennium Research Group

Millennium Research Group (http://www.MRG.net)
'/>"/>

SOURCE Millennium Research Group
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2

Related medicine news :

1. Breast Cancer Imaging Study Indicates Breast-Specific Gamma Imaging (BSGI) Is a Strong Adjunct Imaging Modality to Mammography and Ultrasound
2. Survival differences by race most apparent in advanced stages of breast cancer
3. MRI finds breast cancer before it becomes dangerous
4. Pathway links inflammation, angiogenesis and breast cancer
5. Drop in breast cancer incidence linked to hormone use, not mammograms
6. Breast cancer prevention practices vary across Canada
7. Eating junk food whilst pregnant and breastfeeding may lead to obese offspring
8. Acrylamide Wont Raise Breast Cancer Risk
9. New link between estrogen and breast cancer
10. Hypnosis Eases Pain of Breast Cancer Surgery
11. Discovery suggests location of genes for breast density, a strong risk factor for breast cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2012)... The number of liver transplants in the United States ... Researchers said one reason for the decline is that ... and many of those livers end up being discarded ... attempt a transplant. Another reason livers are discarded is ... fatty liver disease, which is associated with metabolic syndrome ...
(Date:5/22/2012)... The enforcement of Law 42/2010, which extends the smoking ... in the percentage of smokers (from 40.3% to 35.3%) ... applies to men and women of all ages and ... pioneering study, carried out by the Society of Prevention ... Security professionals) analysed the consumption of tobacco in the ...
(Date:5/22/2012)... (HealthDay News) -- Certain gene variants linked to ... lower urinary tract symptoms, according to a new ... variant might protect against those symptoms, the study ... of Medicine at Northwestern University in Chicago identified ... risk in nearly 2,000 healthy, white men enrolled ...
(Date:5/22/2012)... psychiatrists attend their field,s largest annual meeting each year, ... report overwhelmingly on positive results. , That,s the ... Journal of Clinical Psychopharmacology by two young psychiatrists ... analyzed the presentations given at two recent meetings of ... presented at the 2009 and 2010 APA meetings that ...
(Date:5/22/2012)... have determined the genome sequences of a dozen ... to be resistant to vancomycin, an antibiotic of ... independently in each strain, and identified shared features ... acquire vancomycin resistance and evade human immune defenses. ... is a leading cause of hospital-acquired infections in ...
Breaking Medicine News(10 mins):Health News:U.S. Liver Transplants Declining 2Health News:5 percent of workers gave up smoking when the anti-tobacco law took effect 2Health News:Study Ties Genes to Lower Urinary Tract Symptoms, Prostate Cancer Risk 2Health News:Bias found in mental health drug research presented at major psychiatric meeting 2Health News:Bias found in mental health drug research presented at major psychiatric meeting 3Health News:Genomes show how Staph bacteria gain resistance to last-line drug 2
... 26 AARP in Maryland,853,000 members strong, urges ... strengthen the State Children,s Health Insurance Program (SCHIP) ... the state to call the President and tell ... than 100,000 children in Maryland rely on SCHIP ...
... announced the release of $131 million in energy assistance ... energy costs. The,Low Income Home Energy Assistance Program (LIHEAP) ... the fall and winter months,ahead. "No one should ... put states in a better position to help those ...
... 26 Science,Applications International Corporation (NYSE: SAI ... $38 million task order from the U.S. military ... (TMIP-J). The single-award, cost-plus-fixed-fee task order has ... options. The task order was,awarded under the Defense ...
... its ongoing dedication to,serving military members and their families, ... of Fleet Week San Diego, a,month-long celebration of Southern ... 11th year on Sept. 17 and continues until,Oct. 27 ... economic and,cultural importance of military personnel in San Diego, ...
... For many women, digestive issues,have gone from doctor,s ... nearly half of women surveyed say they care,about this ... video from General Mills (NYSE: GIS ) at:, ... is by consuming what are called probiotics.,Probiotics help people ...
... controlled with newer treatments , , WEDNESDAY, Sept. 26 (HealthDay ... small number of longtime HIV patients with mild cases ... plagued people with AIDS. , It,s not clear why ... may pose a significant health threat to AIDS patients. ...
Other Medicine News:Health News:HHS Provides Over $131 Million In Energy Assistance 2Health News:SAIC Selected to Support the U.S. Military Theater Medical Information Program-Joint 2Health News:TriWest On Deck to Support Fleet Week San Diego 2Health News:Doctors See Return of Kaposi's Sarcoma in Handful of AIDS Patients 2
(Date:5/22/2012)... NEW YORK, May 22, 2012  Fox Insurance Company, ... York, NY, announces the confirmation of a judgment in ... pharmacy benefit manager, in excess of $3.3 million, following ... negligence and breach of contract.  On May 21, 2012, ... Georgia, Atlanta Division, issued its decision confirming the arbitration ...
(Date:5/22/2012)... MOUNTAIN VIEW, Calif., May 22, 2012  Based ... market, Frost & Sullivan recognizes Labcyte Inc. with ... for its Echo liquid handler. While various liquid ... incorporates the wide range of advantages provided by ... to revolutionize liquid handling, Labcyte developed a platform ...
(Date:5/22/2012)... Conn., May 22, 2012   Valeritas , ... a new, simple disposable device for the delivery ... 2 diabetes, has selected dLife to ... number-one resource and community network for people living ... V-Go Life, a comprehensive diabetes lifestyle management and ...
Breaking Medicine Technology:Judge Upholds $3.3 Million Judgment In Favor of Fox Insurance Company Against Former Pharmacy Benefit Manager 2Frost & Sullivan Recognizes Labcyte for its Commitment to Innovation and Addressing Unmet Needs in the Liquid Handling Market 2Frost & Sullivan Recognizes Labcyte for its Commitment to Innovation and Addressing Unmet Needs in the Liquid Handling Market 3Frost & Sullivan Recognizes Labcyte for its Commitment to Innovation and Addressing Unmet Needs in the Liquid Handling Market 4Frost & Sullivan Recognizes Labcyte for its Commitment to Innovation and Addressing Unmet Needs in the Liquid Handling Market 5Valeritas Inc. Selects dLife's New Diabetes Patient Engagement Solution For Valeritas' V-go Disposable Insulin Delivery Device 2Valeritas Inc. Selects dLife's New Diabetes Patient Engagement Solution For Valeritas' V-go Disposable Insulin Delivery Device 3Valeritas Inc. Selects dLife's New Diabetes Patient Engagement Solution For Valeritas' V-go Disposable Insulin Delivery Device 4Scripps scientists see the light in bizarre bioluminescent snail 16922 1Scripps scientists see the light in bizarre bioluminescent snail 16922 2Anthera Pharmaceuticals Selects the Merck BioManufacturing Network as Manufacturing Supplier for A 623 Antheras Investigational Novel Peptibody Agent 13285 1Anthera Pharmaceuticals Selects the Merck BioManufacturing Network as Manufacturing Supplier for A 623 Antheras Investigational Novel Peptibody Agent 13285 2Anthera Pharmaceuticals Selects the Merck BioManufacturing Network as Manufacturing Supplier for A 623 Antheras Investigational Novel Peptibody Agent 13285 3Anthera Pharmaceuticals Selects the Merck BioManufacturing Network as Manufacturing Supplier for A 623 Antheras Investigational Novel Peptibody Agent 13285 4Fighting flu in newborns begins in pregnancy 77841 1Fighting flu in newborns begins in pregnancy 77841 2
... JMR-132 could provide a new therapeutic approach for ... CITY, April 17, 2007 /PRNewswire-FirstCall/ - AEterna,Zentaris Inc. ... endocrine therapy and oncology, today presented an,abstract outlining ... antagonist JMR-132 in breast cancer, at the American,Association ...
... previously announced, primary endpoint not met; plausibly,confounded ... ERBITUX,-, NEW YORK, April 16, 2007 /PRNewswire-FirstCall/ ... today,announced detailed results from the EPIC study ... - comparing ERBITUX(R),(Cetuximab) plus irinotecan to irinotecan ...
Other Medicine Technology:AEterna Zentaris Discloses In Vivo Data for its GHRH Antagonist,JMR-132 at the AACR Annual Meeting in Los Angeles 2AEterna Zentaris Discloses In Vivo Data for its GHRH Antagonist,JMR-132 at the AACR Annual Meeting in Los Angeles 3Randomized Phase III Trial Showed Erbitux Significantly Improved,Secondary Endpoints of Progression-Free Survival and Disease,Control in Metastatic Colorectal Cancer Patients 2Randomized Phase III Trial Showed Erbitux Significantly Improved,Secondary Endpoints of Progression-Free Survival and Disease,Control in Metastatic Colorectal Cancer Patients 3Randomized Phase III Trial Showed Erbitux Significantly Improved,Secondary Endpoints of Progression-Free Survival and Disease,Control in Metastatic Colorectal Cancer Patients 4Randomized Phase III Trial Showed Erbitux Significantly Improved,Secondary Endpoints of Progression-Free Survival and Disease,Control in Metastatic Colorectal Cancer Patients 5Randomized Phase III Trial Showed Erbitux Significantly Improved,Secondary Endpoints of Progression-Free Survival and Disease,Control in Metastatic Colorectal Cancer Patients 6Randomized Phase III Trial Showed Erbitux Significantly Improved,Secondary Endpoints of Progression-Free Survival and Disease,Control in Metastatic Colorectal Cancer Patients 7Randomized Phase III Trial Showed Erbitux Significantly Improved,Secondary Endpoints of Progression-Free Survival and Disease,Control in Metastatic Colorectal Cancer Patients 8Randomized Phase III Trial Showed Erbitux Significantly Improved,Secondary Endpoints of Progression-Free Survival and Disease,Control in Metastatic Colorectal Cancer Patients 9
... This increased magnification all glass (1.5x) ... details with more ease., The 4 mirror ... for static and dynamic gonioscopy and features ... high magnification to appreciate details previously unattainable ...
Colloidal Gold Sol, 20 nm - 50 OD, 1 ml, Gold Sol Nanoparticles - not boiled, not centrifuged...
... P2000 Pachymeter [i.e., PalmScan P2000] device ... biometer, which incorporates A-mode pulsed-echo ultrasound,technology, ... accurately measure the corneal thickness (CT) ... PalmScan P2000 includes two software user,interfaces; ...
... A-Scan [i.e., PalmScan A2000] device is intended ... A-mode pulsed-echo ultrasound,technology, and thus may be ... (AL), anterior,chamber depth (ACD), and lens thickness ... is also intended for calculating the optical ...
Medicine Products: